Does INFU pay dividends?

InfuSystems Holdings Inc (INFU) does not currently pay a regular dividend.

What is INFU's P/E ratio?

InfuSystems Holdings Inc has a price-to-earnings (P/E) ratio of 26.91.

What is INFU's market cap?

InfuSystems Holdings Inc (INFU) has a market capitalization of $239.80M with a current stock price of $12.11.

InfuSystems Holdings Inc (INFU)

Official site

HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX

$12.11

+0.07 (+0.58%)

Market Cap: $239.80M

Last updated: Sep 01, 2026 at 10:00 AM ET

Earnings

Performance (10Y)

Beat Rate

58%(15/26)

Avg Surprise

+72.90%

Streak

8 Q

Upcoming Estimates

Sep 30, 2026

EPS Consensus$0.13

Range$0.12 - $0.15

4 analysts

EPS Revisions

30d

EPS Estimate Drift

90d ago$0.13+3.5%

60d ago$0.13+3.9%

30d ago$0.13+3.9%

7d ago$0.13+3.9%

Current$0.13

Revenue Consensus

$37M

Range$37M - $38M

4 analysts

Dec 31, 2026

EPS Consensus$0.16

Range$0.11 - $0.19

4 analysts

Revenue Consensus

$37M

Range$37M - $38M

4 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$0.16	$0.11 - $0.19	-	-	4	-	-
Sep 30, 2026Sep 26EST	-	$0.13	$0.12 - $0.15	-	-	4	1 2 30d	-
Jun 30, 2026Jun 26	$0.15	$0.12	$0.09 - $0.12	+25.00%	Beat	4	0 1 30d	+0.0%
Mar 31, 2026Mar 26	$0.05	$0.03	$-0.01 - $0.06	+66.67%	Beat	5	2 2 30d	-50.0%
Dec 31, 2025Dec 25	$0.10	$0.07	$0.05 - $0.11	+42.86%	Beat	5	1 0 30d	+41.8%
Sep 30, 2025Sep 25	$0.15	$0.05	$0.05 - $0.05	+200.00%	Beat	1	1 0 30d	+15.4%
Jun 30, 2025Jun 25	$0.15	$0.04	$0.04 - $0.04	+275.00%	Beat	1	0 1 30d	+400.0%
Mar 31, 2025Mar 25	$0.10	$-0.03	$-0.03 - $-0.03	+433.33%	Beat	1	0 1 30d	+300.0%
Dec 31, 2024Dec 24	$0.07	$0.06	$0.06 - $0.06	+17.50%	Beat	1	0 1 30d	+2036.4%
Sep 30, 2024Sep 24	$0.13	$0.05	$0.05 - $0.08	+160.00%	Beat	4	No revisions (30d)	+85.7%
Jun 30, 2024Jun 24	$0.03	$0.04	$0.03 - $0.04	-25.00%	Miss	3	No revisions (30d)	+0.0%
Mar 31, 2024Mar 24	$-0.05	$0.01	$-0.01 - $0.05	-600.00%	Miss	3	No revisions (30d)	-400.0%
Dec 31, 2023Dec 23	$0.00	N/A	-	-83.50%	Miss	2	No revisions (30d)	-67.0%
Sep 30, 2023Sep 23	$0.07	$0.09	$0.09 - $0.10	-22.22%	Miss	3	No revisions (30d)	+133.3%
Jun 30, 2023Jun 23	$0.03	N/A	-	-62.50%	Miss	3	No revisions (30d)	+400.0%
Mar 31, 2023Mar 23	$-0.01	N/A	-	-116.67%	Miss	3	No revisions (30d)	+50.0%
Dec 31, 2022Dec 22	$0.01	N/A	-	-75.00%	Miss	3	1 0 30d	-50.0%
Sep 30, 2022Sep 22	$0.03	$0.01	$-0.01 - $0.02	+200.00%	Beat	3	No revisions (30d)	+250.0%
Jun 30, 2022Jun 22	$-0.01	$-0.01	$-0.03 - $0.01	+0.00%	Beat	3	No revisions (30d)	-120.0%
Mar 31, 2022Mar 22	$-0.02	$-0.03	$-0.05 - $0.00	+33.33%	Beat	3	No revisions (30d)	-166.7%
Dec 31, 2021Dec 21	$0.02	N/A	-	-71.43%	Miss	4	No revisions (30d)	-95.9%
Sep 30, 2021Sep 21	$-0.02	$0.01	$-0.02 - $0.06	-300.00%	Miss	4	No revisions (30d)	-114.3%
Jun 30, 2021Jun 21	$0.05	$0.07	$0.04 - $0.13	-28.57%	Miss	4	1 0 30d	-75.0%
Mar 31, 2021Mar 21	$0.03	$0.05	$0.02 - $0.06	-40.00%	Miss	4	No revisions (30d)	+250.0%
Dec 31, 2020Dec 20	$0.49	$0.06	$0.03 - $0.08	+716.67%	Beat	3	No revisions (30d)	+1125.0%
Sep 30, 2020Sep 20	$0.14	$0.04	$0.02 - $0.05	+250.00%	Beat	2	No revisions (30d)	+180.0%
Jun 30, 2020Jun 20	$0.20	$0.02	$0.02 - $0.02	+900.00%	Beat	1	No revisions (30d)	+900.0%
Mar 31, 2020Mar 20	$-0.02	$-0.02	-	+0.00%	Beat	-	-	+60.0%
Dec 31, 2019Dec 19	$0.04	N/A	-	N/A	Beat	-	-	+500.0%
Sep 30, 2019Sep 19	$0.05	N/A	-	N/A	Beat	-	-	+266.7%
Jun 30, 2019Jun 19	$0.02	N/A	-	N/A	Beat	-	-	+200.0%
Mar 31, 2019Mar 19	$-0.05	N/A	-	N/A	Beat	-	-	-600.0%
Dec 31, 2018Dec 18	$-0.01	N/A	-	N/A	Beat	-	-	+75.0%
Sep 30, 2018Sep 18	$-0.03	N/A	-	N/A	Beat	-	-	-200.0%
Jun 30, 2018Jun 18	$-0.02	N/A	-	N/A	Beat	-	-	+60.0%
Mar 31, 2018Mar 18	$0.01	N/A	-	N/A	Beat	-	-	+114.3%
Dec 31, 2017Dec 17	$-0.04	N/A	-	N/A	Beat	-	-	-91.4%
Sep 30, 2017Sep 17	$-0.01	N/A	-	N/A	Beat	-	-	-516.7%
Jun 30, 2017Jun 17	$-0.05	N/A	-	N/A	Beat	-	-	-
Mar 31, 2017Mar 17	$-0.07	N/A	-	N/A	Beat	-	-	-
Dec 31, 2016Dec 16	$-0.02	N/A	-	N/A	Beat	-	-	-
Sep 30, 2016Sep 16	$0.00	N/A	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	26.91	EV/EBITDA	9.95x
Price/FCF	10.61x	FCF Yield	9.42%
Profitability
Profit Margin	5.96%	Operating Margin	11.20%
ROE	15.00%	ROIC	11.70%
Financial Health
Debt/Equity	0.35x	Interest Coverage	12.10x
Current Ratio	2.50x	Quick Ratio	2.14x
Trading Statistics
Beta	1.46	Avg Volume	156.32K
52-Week High	$12.97	52-Week Low	$7.29

Technical Indicators Dashboard

Moving Averages

SMA 10$12.11

SMA 20$12.18

SMA 50$10.51

SMA 200$9.48

EMA 10$12.05

EMA 20$11.76

EMA 50$10.89

EMA 200$9.64

MACD

Line: 0.47Signal: 0.58Hist: -0.11

ADX

ADX: 35.7+DI: 27.5-DI: 12.9

Aroon & PSAR

Aroon Up28.0

Aroon Down16.0

PSAR$12.90

Bollinger Bands

Upper Band$12.52

Lower Band$11.84

%B Position552%(Upper)

Band Width0.40

RSI (14-Day)

Neutral

61.8

Momentum Oscillators

Stoch %K37.3

Stoch %D39.8

Williams %R-57.3

ROC (10d)-0.4%

Momentum-0.05

CCI (20d)-18.9

MFI (14d)43.5

Volatility Measures

ATR (14d)$0.43(3.6%)

StdDev (20d)0.17

Hist Vol123.3%(High)

Volume Flow

VWAP$12.09

OBV2.4M

AD Line4.5M

CMF (20d)0.184

Volume Metrics

Avg Vol (20d)152.2K

Vol Ratio0.5x

VWMA (20d)$12.21

Pivot Points

R3$12.27

R2$12.19

R1$12.12

Pivot Point$12.03

S1$11.96

S2$11.88

S3$11.80

Advanced Oscillators

TSI26.19

Ultimate Osc55.0

KST230.31

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$36.93M	$33.68M	$36.23M	$36.49M	$36.00M	$34.72M	$33.85M	$35.32M	$33.70M	$32.00M	$31.77M	$31.91M
Cost of Revenue	$15.52M	$14.00M	$15.79M	$15.67M	$16.13M	$15.55M	$15.63M	$16.27M	$17.03M	$15.52M	$15.06M	$16.29M
Gross Profit	$21.41M	$19.68M	$20.43M	$20.82M	$19.87M	$19.17M	$18.22M	$19.05M	$16.67M	$16.47M	$16.71M	$15.62M

Operating Expenses	$17.26M	$18.09M	$16.72M	$17.01M	$16.10M	$18.55M	$15.60M	$15.78M	$14.81M	$17.32M	$15.46M	$13.92M
R&D	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
SG&A	$14.10M	$14.80M	$14.08M	$14.43M	$13.15M	$15.32M	$13.21M	$12.78M	$11.52M	$13.70M	$11.50M	$10.94M
Operating Income	$4.15M	$1.59M	$3.71M	$3.81M	$3.78M	$618,000	$2.62M	$3.27M	$1.85M	$-845,000	$1.25M	$1.70M

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$255,000	$255,000	$260,000	$330,000	$373,000	$336,000	$361,000	$476,000	$484,000	$456,000	$503,000	$563,000
Income Before Tax	$3.87M	$1.42M	$3.50M	$3.43M	$3.45M	$253,000	$2.26M	$2.79M	$1.31M	$-1,298,000	$727,000	$1.12M
Income Tax Expense	$640,000	$400,000	$1.46M	$1.17M	$847,000	$520,000	$1.33M	$978,000	$591,000	$-186,000	$655,000	$431,000

Net Income	$3.23M	$1.02M	$2.04M	$2.26M	$2.60M	$-267,000	$933,000	$1.81M	$717,000	$-1,112,000	$72,000	$689,000

EBITDA	$7.32M	$4.95M	$7.13M	$7.06M	$7.18M	$3.93M	$6.07M	$6.42M	$4.84M	$2.08M	$4.39M	$4.77M
EBIT	$4.13M	$1.67M	$3.76M	$3.76M	$3.82M	$589,000	$2.63M	$3.26M	$1.79M	$-842,000	$1.23M	$1.68M

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about INFU

News

INFU Financials: Revenue Breakdown, Margins & Competitor Comparison

This article analyzes the financial performance of InfuSystem Holdings Inc (INFU), detailing its revenue breakdown, profitability margins, and a comparison with competitors. Patient Services is the largest revenue contributor, and the company maintains strong gross, operating, and net margins. INFU's financial health and market position are evaluated against industry leaders.

Intellectia AI•Aug 22, 2026 9:42 AM8/22/26•

Bullish

INFU | InfuSystem Holdings, Inc. Financials - Revenue Breakdown

This article provides a detailed financial overview of InfuSystem Holdings, Inc. (INFU), focusing on its revenue breakdown, alongside other financial metrics and data points. It covers aspects like insider trading, institutional holdings, analyst ratings, and a company description, but explicitly states no revenue breakdown data is available by segment or geography. The company is described as a healthcare service provider specializing in outpatient care for durable medical equipment.

Quiver Quantitative•Aug 15, 2026 7:40 PM8/15/26•

Neutral

InfuSystem (NYSE:INFU) Trading Down 1.8% - What's Next?

InfuSystem Holdings, Inc. (NYSE:INFU) saw its shares drop by 1.8% in Wednesday trading, closing at $12.24. Despite the dip, B. Riley reiterated a "Buy" rating and increased its price target to $20, contributing to a "Moderate Buy" consensus among analysts. The company also announced a $20 million share repurchase program, indicating management believes the stock is undervalued.

MarketBeat•Aug 13, 2026 4:42 AM8/13/26•

Somewhat-Bullish

INFUSYSTEM HOLDINGS INC : B. RILEY RAISES TARGET PRICE TO $20 FROM $12

B. Riley has increased its target price for InfuSystem Holdings Inc. (INFU) to $20, up from its previous target of $12. This revision suggests a positive outlook from the analyst firm regarding the company's future stock performance.

Webull•Aug 6, 2026 6:42 AM8/6/26•

Bullish

InfuSystem Earnings Call Highlights Growth Amid Headwinds

InfuSystem Holdings, Inc. reported record quarterly revenue and improved adjusted EBITDA, driven by strong oncology and wound care segments, despite headwinds from a restructured GE Healthcare contract and increased operating expenses. The company reaffirmed its 2026 revenue growth guidance and aims for continued margin expansion, positioning itself as a disciplined healthcare services provider focused on strategic growth and conservative leverage.

The Globe and Mail•Aug 6, 2026 12:41 AM8/6/26•

Somewhat-Bullish

Frequently Asked Questions About INFU

Does INFU pay dividends?: InfuSystems Holdings Inc (INFU) does not currently pay a regular dividend.
What is INFU's P/E ratio?: InfuSystems Holdings Inc has a price-to-earnings (P/E) ratio of 26.91.
What is INFU's market cap?: InfuSystems Holdings Inc (INFU) has a market capitalization of $239.80M with a current stock price of $12.11.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In